Monday, December 4, 2023

Latest:

3 trends in the “medaverse” that critically impact healthcare
All about prosthesis
How neurotransmitters work together to detect odors
Turf vs. grass: field of dreams or field of injuries?
Baylor surgeon treats rare condition

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

RSV

Unlocking the Secrets of Maternal RSV Immunization: What Every Parent Should Know

November 10, 2023November 2, 2023 Abrysvo, maternal health, maternal immunization, Pfizer’s bivalent RSVpreF (Abrysvo), pregnant, Respiratory Syncytial Virus (RSV), RSV

On May 18, 2023, the FDA voted to approve Pfizer’s bivalent RSVpreF (Abrysvo) vaccine for pregnant women to protect their newborns against respiratory syncytial virus

From The Labs

Miniature model of the human nose reveals early events of SARS-CoV-2 and RSV infection

February 22, 2022February 28, 2022 COVID-19, human nose model, human nose organoid, palivizumab, Research, RSV, SARS-CoV-2

Researchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.

From The Labs

Antibody response and ‘original antigenic sin’ in RSV influence vaccine development

February 11, 2021February 11, 2021 COVID-19, immunity to RSV, Research, RSV, RSV antibodies, vaccine development

Variation of human immune response to RSV reinfection suggests it is important to consider this variation in vaccine design.

From the Labs: Neural connections in the visual pathway of the brain